跳至主要内容
临床试验/NCT04800861
NCT04800861已完成不适用

Glycemic Control in Diabetic Hospitalized Patients: a Cross Sectional Study

AlFayhaa General Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
glycemic control

研究概览

简要总结

With the advanced management of diabetes and new innovative anti-hyperglycemic therapy hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the hospital in general wards. Efforts from health care providers to assess and control blood sugar by a simplified method such as certified point of care hand-sized glucometers is the fruitful protocol if the results near the target that is endorsed by well-known diabetes societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl after a meal. The unstable economy and political crises with the pandemic of Covid-19 making us use a glucometer to monitor and control the fluctuation of blood sugar in order to decrease the burden on the patients and health care providers in the form of a stay in the hospital and minimize wasting laboratory resources.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • admitted to the hospital

排除标准

  • 未提供

结局指标

主要结局

glycemic control

时间窗: From hospital admission to hospital discharge for a median of 7 days and up to 1 month

percentage of patients with glucose measurement (Random Blood Sugar, RBS, Fasting Blood Sugar, FBS) between 140-180 measured with bedside glucometers preferably before meals and at 6 am for fasting blood sugars or as directed by the physician

次要结局

  • average per patient(From hospital admission to hospital discharge for a median of 7 days and up to 1 month)
  • average blood glucose value per ward(From hospital admission to hospital discharge for a median of 7 days and up to 1 month)

研究者

发起方
AlFayhaa General Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Glycemic Control in Diabetic Hospitalized Patients | 临床试验